176 related articles for article (PubMed ID: 8224452)
21. Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.
van Zandwijk N; Jassem E; Bonfrer JM; van Tinteren H
Eur J Cancer; 1990 Mar; 26(3):373-6. PubMed ID: 2162690
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.
Body JJ; Paesmans M; Sculier JP; Dabouis G; Bureau G; Libert P; Berchier MC; Raymakers N; Klastersky J
Clin Chem; 1992 May; 38(5):748-51. PubMed ID: 1316245
[TBL] [Abstract][Full Text] [Related]
23. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
24. [Serum level of neuron-specific enolase: value as tumor marker of microcellular bronchial cancer].
Weynants P; Bauduin M; Majois F; Moens D; De Nayer P
Acta Clin Belg; 1989; 44(3):161-8. PubMed ID: 2554629
[TBL] [Abstract][Full Text] [Related]
25. [Serum neuron-specific enolase in patients with lung cancer].
Matsubara Y; Yasuda Y; Yagi K; Ike O; Aoki M; Miyamoto Y; Hatakenaka R; Ninomiya K; Funatsu T; Ikeda S
Nihon Gan Chiryo Gakkai Shi; 1985 Jul; 20(6):1136-45. PubMed ID: 2999271
[No Abstract] [Full Text] [Related]
26. Clinical significance of a multiple biomarker assay in patients with lung cancer. A study with logistic regression analysis.
Lombardi C; Tassi GF; Pizzocolo G; Donato F
Chest; 1990 Mar; 97(3):639-44. PubMed ID: 1689630
[TBL] [Abstract][Full Text] [Related]
27. Performance characteristics of seven neuron-specific enolase assays.
Stern P; Bartos V; Uhrova J; Bezdickova D; Vanickova Z; Tichy V; Pelinkova K; Prusa R; Zima T
Tumour Biol; 2007; 28(2):84-92. PubMed ID: 17259755
[TBL] [Abstract][Full Text] [Related]
28. [Primary small-cell bronchial cancer: value of serum tumor markers in the prognostic evaluation].
Watine J; Charet JC
Presse Med; 1999 Sep; 28(28):1541-6. PubMed ID: 10526565
[TBL] [Abstract][Full Text] [Related]
29. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
[TBL] [Abstract][Full Text] [Related]
30. Neurone-specific enolase and liver metastasis in small cell lung cancer.
Kanemoto K; Satoh H; Ishikawa H; Sekizawa K
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):505. PubMed ID: 16909976
[No Abstract] [Full Text] [Related]
31. Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer.
Spinazzi A; Soresi E; Borghini U; Boffi R; Vigorelli R; Scoccia S
J Nucl Med Allied Sci; 1990; 34(4 Suppl):141-5. PubMed ID: 1965446
[No Abstract] [Full Text] [Related]
32. Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice.
Splinter TA; Carney DN; Teeling M; Peake MD; Kho GS; Oosterom R; Cooper EH
J Cancer Res Clin Oncol; 1989; 115(4):400-1. PubMed ID: 2547802
[TBL] [Abstract][Full Text] [Related]
33. Tumour marker evaluation in patients with lung cancer.
Seregni E; Botti C; Bogni A; Bombardieri E
Scand J Clin Lab Invest Suppl; 1995; 221():67-71. PubMed ID: 7652492
[No Abstract] [Full Text] [Related]
34. Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles.
Paus E; Nustad K
Clin Chem; 1989 Oct; 35(10):2034-8. PubMed ID: 2551540
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a new IRMA method for the determination of neuron specific enolase.
Mione R; Bombardieri E; Gion M; Gatti C; Bruscagnin G
Int J Biol Markers; 1990; 5(3):155-6. PubMed ID: 1962809
[No Abstract] [Full Text] [Related]
36. Prognostic and diagnostic usefulness of serum markers in lung cancer.
Stahel RA; Martz G
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):893-4. PubMed ID: 2822425
[No Abstract] [Full Text] [Related]
37. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
38. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
[TBL] [Abstract][Full Text] [Related]
39. [Neuron-specific enolase--a selective marker of small cell bronchial cancer].
Lorenz J; Mai GA; Schulz V
Prax Klin Pneumol; 1986 Mar; 40(3):100-2. PubMed ID: 3012500
[No Abstract] [Full Text] [Related]
40. [Relation between serum neuron-specific enolase and CEA levels in the patients with lung cancer].
Hou LP
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Aug; 11(4):219-21, 255. PubMed ID: 2852546
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
